Plan B One-Step will be available OTC without age or sale restrictions
The Obama administration will not fight the April 5 ruling of a federal judge that one-dose emergency contraception must be available for all ages without a prescription
We applaud and share in California pharmacists’ efforts on behalf of patient access to their services as the California state Senate approved its pharmacist provider status bill (SB 493) late last week, a significant step in becoming law. The legislation is now with the California State Assembly for consideration. I appreciate the efforts by California Senator Hernandez, an optometrist, in sponsoring and shepherding the passage of SB 493 to help address California’s shortage of primary care services.
The legislation not only expands the scope of practice for pharmacy, but also specifically names pharmacists as providers. SB 493 recognizes pharmacists’ education, training, and abilities as health care providers by expanding the list of services pharmacists can provide in the state.
If signed into law, examples of new authorities for pharmacists in California would include ordering and interpreting tests to monitor and manage the efficacy and toxicity of drug therapies and initiating and administering routine vaccinations.
In a brief note posted on the California Pharmacists Association (CPhA) website, CPhA described months of lobbying and member letter-writing. We join CPhA, the California Society of Health-System Pharmacists, and other groups in celebrating this important step forward, and thank those involved for all their hard work.
And guess who has the dictionary in their heads? That’s right, we do!
An important new study suggests that statins, the cholesterol-lowering medications that are the most prescribed drugs in the world, may block some of the fitness benefits of exercise, one of the surest ways to improve health.
No one is saying that people with high cholesterol or a family history of heart disease should avoid statins, which studies show can be lifesaving. But the discovery could create something of dilemma for doctors and patients, since the people who should benefit the most from exercise — those who are sedentary, overweight, at risk of heart disease or middle-aged — are also the people most likely to be put on statins, possibly undoing some of the good of their workouts.
SAN FRANCISCO — A central nervous stimulant, lisdexamfetamine dimesylate (LDX, Vyvanse, Shire), a medication approved for the treatment and maintenance of attention-deficit/hyperactivity disorder (ADHD), may also reduce harmful behaviors in those with binge eating disorder (BED), new research suggests.
The phase 2 trial in adults with moderate to severe BED showed that those who received LDX had significantly fewer bingeing episodes after 11 weeks of treatment compared with the placebo group.
The FDA has approved a new dry powder inhaler (marketed as Breo Ellipta) to increase airflow and reduce exacerbations in patients with chronic obstructive pulmonary disease. The once-daily maintenance therapy combines the inhaled corticosteroid fluticasone furoate with vilanterol, a long-acting β2-adrenergic agonist (LABA).
FDA approves morning-after pill without prescription for girls 15 and older
The U.S. Food and Drug Administration announced Tuesday that it approved the availability of the Plan B One-Step emergency contraception pill without a prescription for women 15 and older.
“Research has shown that access to emergency contraceptive products has the potential to further decrease the rate of unintended pregnancies in the United States,” said FDA Commissioner Dr. Margaret A. Hamburg in a statement. “The data reviewed by the agency demonstrated that women 15 years of age and older were able to understand how Plan B One-Step works, how to use it properly, and that it does not prevent the transmission of a sexually transmitted disease.”
Thank you for the submission! I was going to post this after going through my presentation, but you got there first!!!